Vioxx,
Bextra, Celebrex, Serevent, Meridia, Crestor
"In
April of 2004, my father suffered a stroke. I am grateful
to God for the physicians and nurses that battled for
months to save his life. I know firsthand the real
tragedy that follows the stroke victim.
During the Summer of 2004, the storm clouds
began to gather in the pharmaceutical world regarding the
distribution of Vioxx, Celebrex, and Bextra. Finally, on
November 15, 2004, after much deliberation over an
article from the New York Times ("New
Study Links Pfizer's Bextra, Similar to Vioxx, To Heart
Attacks", By Gardiner Harris, NYT, Nov 10, 2004),
I decided it was time for me to get involved. Please read
this article.
Although my father's plight was not caused
by Vioxx, Celebrex, or Bextra, the
thought that a pharmaceutical company, operating for profit, might knowingly place these
substances in the hands of an unsuspecting public, became
more than I was willing to ignore.
I have litigated a wide
range of civil and criminal cases. Mostly, my practice
has involved jury trials with a variety of special circumstances.
This website provides an insight into the extensive legal
background of this office and my practice. We believe in
protecting our clients' rights to legal redress; every
civil juror is a citizen that wants to protect his neighbor
from a careless corporate actor."
Article References:
- US FDA reviewer says 5 drugs need closer scrutiny by
Lisa Richwine and Ransdell Pierson, Reuters, Updated:
5:32 p.m. ET Nov. 18, 2004 - "A
U.S. Food and Drug Administration reviewer who has accused
the agency of being lax in monitoring drug safety on
Thursday said five medicines on the market need closer
scrutiny."...read
more via pdf
- FDA
reviewer says five drugs now on market are so worrisome
they deserve another look byDiedtra
Henderson, AP Science Writer
Thursday, November 18, 2004, 17:31 PST WASHINGTON (AP) - "At
least five medications now sold to consumers pose such risks that their sale
should be limited or stopped, said a government drug reviewer who raised safety
questions earlier about the arthritis drug Vioxx." ...read more
via pdf
- Cases
of Kidney Failure, Muscle Damage Should Prompt FDA
to Ban Crestor, Washington,
D.C. – "Public
Citizen today called on the U.S. Food and Drug Administration
(FDA) to immediately remove the cholesterol-lowering
drug rosuvastatin from the market. The drug, marketed
by AstraZeneca as Crestor, has been linked to cases
of life-threatening muscle damage and kidney failure
or damage." ...read
more via pdf ,
|
